US20230093940A1 - Bioreactor with addition tube - Google Patents

Bioreactor with addition tube Download PDF

Info

Publication number
US20230093940A1
US20230093940A1 US18/062,481 US202218062481A US2023093940A1 US 20230093940 A1 US20230093940 A1 US 20230093940A1 US 202218062481 A US202218062481 A US 202218062481A US 2023093940 A1 US2023093940 A1 US 2023093940A1
Authority
US
United States
Prior art keywords
bioreactor
vessel
check valve
addition tube
inner volume
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
US18/062,481
Inventor
Andreas Castan
Klaus Gebauer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cytiva Sweden AB
Original Assignee
Cytiva Sweden AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52587036&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20230093940(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cytiva Sweden AB filed Critical Cytiva Sweden AB
Priority to US18/062,481 priority Critical patent/US20230093940A1/en
Assigned to CYTIVA SWEDEN AB reassignment CYTIVA SWEDEN AB CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: GE HEALTHCARE BIO-SCIENCES AB
Assigned to GE HEALTHCARE BIO-SCIENCES AB reassignment GE HEALTHCARE BIO-SCIENCES AB ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CASTAN, ANDREAS, GEBAUER, KLAUS
Publication of US20230093940A1 publication Critical patent/US20230093940A1/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M29/00Means for introduction, extraction or recirculation of materials, e.g. pumps
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M21/00Bioreactors or fermenters specially adapted for specific uses
    • C12M21/08Bioreactors or fermenters specially adapted for specific uses for producing artificial tissue or for ex-vivo cultivation of tissue
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00Constructional details, e.g. recesses, hinges
    • C12M23/02Form or structure of the vessel
    • C12M23/14Bags
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00Constructional details, e.g. recesses, hinges
    • C12M23/26Constructional details, e.g. recesses, hinges flexible
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M23/00Constructional details, e.g. recesses, hinges
    • C12M23/38Caps; Covers; Plugs; Pouring means
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M27/00Means for mixing, agitating or circulating fluids in the vessel
    • C12M27/02Stirrer or mobile mixing elements
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M27/00Means for mixing, agitating or circulating fluids in the vessel
    • C12M27/16Vibrating; Shaking; Tilting
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M29/00Means for introduction, extraction or recirculation of materials, e.g. pumps
    • C12M29/14Pressurized fluid
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/16Yeasts; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/04Plant cells or tissues
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0601Invertebrate cells or tissues, e.g. insect cells; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells

Definitions

  • the present invention relates to bioreactors, and more particularly to addition tubes for bioreactors.
  • the invention also relates to cultivation of cells in bioreactors with addition tubes.
  • cells are commonly cultivated with the purpose either to recover products expressed by the cells, such as proteins, vaccine components etc. or to recover e.g. stem cells for therapeutic use.
  • the cultivation conditions need to be carefully controlled and it is common practice to add reagents such as pH regulators, gases, nutrients, antifoam etc. to the culture during cultivation. This is done by pumping through an addition tube, which can have a delivery orifice (usually the end of the tube) either immersed in the cell culture medium or suspended above the cell culture medium.
  • the pump is typically run intermittently, either controlled by a feedback loop or by a fixed addition program.
  • reagent may be delivered by dripping or diffusion even when the pump is stopped, causing poor control of the reagent supply.
  • a further issue is also that cell culture medium and cells may enter the tube and be subjected to highly toxic conditions leading to cell death and release of detrimental signal substances.
  • the reagent may also go primarily into the foam layer on top of the medium, preventing proper distribution in the culture.
  • One aspect of the invention is to provide a means for well-controlled addition of reagents to cell cultures. This is achieved with a bioreactor as defined in claim 1 .
  • reagents are only delivered when intended and in the amounts intended. Further advantages are that the reagents are evenly distributed and that cells are not exposed locally to high transient reagent concentrations.
  • Another aspect of the invention is to provide a method of cultivating cells with well-controlled addition of reagents. This is achieved with a cell cultivation method as defined in the claims.
  • FIG. 1 shows a bioreactor according to the invention.
  • FIG. 2 shows a bioreactor according to the invention, with a plastic bag supported by a rigid structure.
  • FIG. 3 shows a bioreactor according to the invention, with an inflatable bag resting on a movable platform.
  • FIG. 4 shows a detailed picture of an addition tube of the invention, with a split disk check valve.
  • FIG. 5 shows a detailed picture of an addition tube of the invention, with a lip (duckbill) check valve.
  • FIG. 6 shows a detailed picture of an addition tube of the invention, with a tubular check valve.
  • FIG. 7 shows a detailed picture of an addition tube of the invention, with a flap check valve.
  • the present invention discloses a bioreactor 1 ; 11 ; 21 comprising a vessel 2 ; 22 which defines an inner volume 3 ; 23 .
  • the bioreactor further comprises agitation means 4 ; 24 and at least one addition tube 5 ; 25 , where a delivery orifice 6 ; 26 in the addition tube is located within the inner volume of the vessel and a check valve 7 ; 27 is arranged in proximity of, or adjacent, the delivery orifice such that it allows flow of a fluid in the direction from the addition tube into the inner volume 3 ; 23 and blocking flow in the reverse direction.
  • check valve 7 ; 27 is arranged in proximity of delivery orifice 6 ; 26 , the distance between the check valve and the orifice may be e.g.
  • the vessel can typically have a volume from 0.1 litres up to several thousand litres and the diameter of the addition tube can correspondingly be from about 1 mm up to several cm.
  • the addition tube can be connected with a port in a wall of the vessel and this port can during use of the bioreactor be connected, e.g. with tubing, to a fluid supply vessel and to a pressure-generating delivery means.
  • the delivery means can e.g. be a pump, a pressurized fluid supply vessel or a fluid supply vessel placed above the bioreactor to generate a hydrostatic pressure.
  • the delivery of fluid can be controlled e.g by switching or regulating a pump or by opening/closing a regulator valve in the tubing.
  • the delivery orifice 6 ; 26 of the addition tube is arranged to be immersed in liquid during use of the bioreactor. This has the advantage that the fluid is added directly into the cell culture liquid and there is no risk of fluid being trapped in the foam layer formed on top of the liquid during cultivation.
  • the addition tube can e.g. be connected with a port in a top wall of the vessel and the addition tube can have a length sufficient to reach down at least halfway to a bottom wall of the vessel, such as at least 80% or at least 90% of the distance from the top wall to the bottom wall, with the delivery orifice located at or in proximity of a bottom end of the addition tube.
  • the bioreactor should in these cases be supplied with an instruction to fill the vessel with sufficient liquid for immersion of the delivery orifice during use.
  • the addition tube can alternatively also be connected with a port in a side wall or a bottom wall of the vessel and even in these cases the vessel should be filled with sufficient liquid for immersion of the delivery orifice during use.
  • the position of the delivery orifice in the vessel is adjustable. This can be achieved e.g. with a telescopic addition tube, bellows in a vessel wall port to which the addition tube is connected, etc. and has the advantage that the delivery orifice can be immersed and positioned at a point of high turbulence regardless of the degree of filling of the vessel.
  • the delivery orifice 6 ; 26 of the addition tube is covered by the check valve 7 ; 27 .
  • An advantage of this is that the cell culture liquid is in direct contact with the check valve and no stagnant zones are formed outside the check valve.
  • the check valve itself can suitably be constructed such that no stagnant zones are formed on its outside. Examples of such check valves are illustrated in FIGS. 4 - 7 .
  • the check valve is inserted in the addition tube, e.g. at a position in proximity of the delivery orifice.
  • the opening pressure of said check valve is below or equal to 10 kPa, such as between 10 Pa and 10 kPa, between 100 Pa and 10 kPa or between 1 kPa and 10 kPa.
  • a too high opening pressure can give rise to pressure build-up and uncontrolled burst of fluid, while a too low opening pressure may cause the valve to open e.g. from pressure fluctuations induced by the agitation.
  • the opening pressure is the minimum pressure difference between the two sides (inlet side and outlet side) of the check valve, which will cause the check valve to open. It can easily be determined with standard method, e.g. by gradually increasing the pressure on the inlet side and noting at which pressure the valve opens.
  • the check valve comprises an elastomeric closing member 38 ; 48 ; 58 ; 68 .
  • Elastomeric closing members facilitate the construction of check valves without stagnant zones and are well compatible with single use bioreactor vessels. It is also possible to have an addition tube with an integrally formed elastomeric check valve closing member, such that no separate assembly of valve parts is needed.
  • the elastomeric closing member is selected from the group consisting of tubes, lips, flaps and split disks.
  • An example of a tubular closing member 58 is shown in FIG. 6 , an example of lips 48 in FIG. 5 , a flap 68 in FIG. 7 and a split disk 38 in FIG. 4 . All these constructions can be made with no or minimal outside stagnant zones and they are suitable for use in bioreactors.
  • the vessel comprises a flexible plastic bag 2 ; 22 .
  • the flexible plastic bag 2 can e.g. be supported by a rigid support structure 18 during use.
  • the rigid support structure can be made from e.g. stainless steel.
  • the agitation means comprises an impeller 4 .
  • the impeller is suitably located in the inner volume of the vessel and can be arranged to rotate or oscillate, e.g. by the action of an external magnetic drive.
  • the flexible plastic bag 22 is inflatable and the agitation means comprises a movable support platform 24 for the flexible plastic bag. As illustrated in FIG. 3 , the inflated bag can be self-supporting and can rest on the platform 24 , which can be movable around an axis 28 to generate an oscillatory rocking agitation.
  • the bioreactor or the vessel, including the addition tube and optionally the agitation means is radiation sterilized. This is convenient for single-use bioreactors and can be achieved when all the components are made from radiation stable materials.
  • Suitable materials for the vessel and the addition tube can be e.g. polyethylene and ethylene copolymers, while suitable elastomers for the closing member of the check valve can be e.g. radiation stable silicones.
  • the addition tube is fluidically connected to a supply vessel containing a liquid solution comprising a pH regulator, a nutrient and/or a growth factor.
  • the liquid solution can be e.g. aqueous ammonia for pH control, but it can also be more complex media component solutions.
  • the present invention discloses a method of cell cultivation, which comprises the steps of:
  • the cells can be e.g. i) animal cells, such as mammalian or insect cells, ii) microorganisms such as bacteria or yeast cells or iii) plant cells.
  • the amount of cell cultivation medium in step b) is sufficient to immerse the delivery orifice of the addition tube.
  • the liquid solution comprises a pH regulator, a nutrient and/or a growth factor.

Abstract

The invention discloses a bioreactor with a vessel defining an inner volume, agitation means and at least one addition tube, wherein a delivery orifice in the addition tube is located within the inner volume and a check valve is arranged in proximity of the delivery orifice for allowing flow of a fluid in the direction from the addition tube into the inner volume of the vessel and blocking flow in the reverse direction.

Description

    CROSS REFERENCE TO RELATED APPLICATIONS
  • This application is a continuation of U.S. application Ser. No. 14/910,824, filed on Feb. 8, 2016, which claims the priority benefit of PCT/SE2013/051001, filed on Aug. 27, 2013. The entire contents of which are incorporated herein by reference.
  • TECHNICAL FIELD OF THE INVENTION
  • The present invention relates to bioreactors, and more particularly to addition tubes for bioreactors. The invention also relates to cultivation of cells in bioreactors with addition tubes.
  • BACKGROUND OF THE INVENTION
  • In the biopharmaceutical and Life Sciences industries, cells are commonly cultivated with the purpose either to recover products expressed by the cells, such as proteins, vaccine components etc. or to recover e.g. stem cells for therapeutic use. The cultivation conditions need to be carefully controlled and it is common practice to add reagents such as pH regulators, gases, nutrients, antifoam etc. to the culture during cultivation. This is done by pumping through an addition tube, which can have a delivery orifice (usually the end of the tube) either immersed in the cell culture medium or suspended above the cell culture medium. The pump is typically run intermittently, either controlled by a feedback loop or by a fixed addition program. One issue is then that reagent may be delivered by dripping or diffusion even when the pump is stopped, causing poor control of the reagent supply. When the delivery orifice is immersed, a further issue is also that cell culture medium and cells may enter the tube and be subjected to highly toxic conditions leading to cell death and release of detrimental signal substances. When the delivery orifice is suspended above the medium, the reagent may also go primarily into the foam layer on top of the medium, preventing proper distribution in the culture.
  • Accordingly there is a need for a well-controlled method of adding reagents to a cell culture with no risk of cells being subjected to overly high local reagent concentrations.
  • SUMMARY OF THE INVENTION
  • One aspect of the invention is to provide a means for well-controlled addition of reagents to cell cultures. This is achieved with a bioreactor as defined in claim 1.
  • One advantage is that reagents are only delivered when intended and in the amounts intended. Further advantages are that the reagents are evenly distributed and that cells are not exposed locally to high transient reagent concentrations.
  • Another aspect of the invention is to provide a method of cultivating cells with well-controlled addition of reagents. This is achieved with a cell cultivation method as defined in the claims.
  • Further suitable embodiments of the invention are described in the dependent claims.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 shows a bioreactor according to the invention.
  • FIG. 2 shows a bioreactor according to the invention, with a plastic bag supported by a rigid structure.
  • FIG. 3 shows a bioreactor according to the invention, with an inflatable bag resting on a movable platform.
  • FIG. 4 shows a detailed picture of an addition tube of the invention, with a split disk check valve.
  • FIG. 5 shows a detailed picture of an addition tube of the invention, with a lip (duckbill) check valve.
  • FIG. 6 shows a detailed picture of an addition tube of the invention, with a tubular check valve.
  • FIG. 7 shows a detailed picture of an addition tube of the invention, with a flap check valve.
  • DETAILED DESCRIPTION OF EMBODIMENTS
  • In one aspect the present invention discloses a bioreactor 1;11;21 comprising a vessel 2;22 which defines an inner volume 3;23. The bioreactor further comprises agitation means 4;24 and at least one addition tube 5;25, where a delivery orifice 6;26 in the addition tube is located within the inner volume of the vessel and a check valve 7;27 is arranged in proximity of, or adjacent, the delivery orifice such that it allows flow of a fluid in the direction from the addition tube into the inner volume 3;23 and blocking flow in the reverse direction. When check valve 7;27 is arranged in proximity of delivery orifice 6;26, the distance between the check valve and the orifice may be e.g. up to 20 times the diameter of tube 5;25, such as up to 10 times, up to 5 times or up to 2 times the diameter of tube 5;25 (or the average diameter if the diameter varies along the length of tube 5;25). Short distances are advantageous due to the smaller dead volumes, but it can be easier to accommodate the check valve in the tube if some distance is allowed, When a fluid, such as a pH regulating solution, a nutrient solution, a growth factor solution or a gas is supplied to the inner volume via the addition tube and the delivery orifice, the check valve opens and when no fluid is supplied the valve is closed, blocking any convective or diffusive permeation of fluid from the inner volume into the addition tube. The vessel can typically have a volume from 0.1 litres up to several thousand litres and the diameter of the addition tube can correspondingly be from about 1 mm up to several cm. The addition tube can be connected with a port in a wall of the vessel and this port can during use of the bioreactor be connected, e.g. with tubing, to a fluid supply vessel and to a pressure-generating delivery means. The delivery means can e.g. be a pump, a pressurized fluid supply vessel or a fluid supply vessel placed above the bioreactor to generate a hydrostatic pressure. The delivery of fluid can be controlled e.g by switching or regulating a pump or by opening/closing a regulator valve in the tubing.
  • In some embodiments, the delivery orifice 6;26 of the addition tube is arranged to be immersed in liquid during use of the bioreactor. This has the advantage that the fluid is added directly into the cell culture liquid and there is no risk of fluid being trapped in the foam layer formed on top of the liquid during cultivation. The addition tube can e.g. be connected with a port in a top wall of the vessel and the addition tube can have a length sufficient to reach down at least halfway to a bottom wall of the vessel, such as at least 80% or at least 90% of the distance from the top wall to the bottom wall, with the delivery orifice located at or in proximity of a bottom end of the addition tube. The bioreactor should in these cases be supplied with an instruction to fill the vessel with sufficient liquid for immersion of the delivery orifice during use. The addition tube can alternatively also be connected with a port in a side wall or a bottom wall of the vessel and even in these cases the vessel should be filled with sufficient liquid for immersion of the delivery orifice during use.
  • In certain embodiments, the position of the delivery orifice in the vessel is adjustable. This can be achieved e.g. with a telescopic addition tube, bellows in a vessel wall port to which the addition tube is connected, etc. and has the advantage that the delivery orifice can be immersed and positioned at a point of high turbulence regardless of the degree of filling of the vessel.
  • In some embodiments, the delivery orifice 6;26 of the addition tube is covered by the check valve 7;27. An advantage of this is that the cell culture liquid is in direct contact with the check valve and no stagnant zones are formed outside the check valve. The check valve itself can suitably be constructed such that no stagnant zones are formed on its outside. Examples of such check valves are illustrated in FIGS. 4-7 .
  • In some embodiments, the check valve is inserted in the addition tube, e.g. at a position in proximity of the delivery orifice.
  • In certain embodiments, the opening pressure of said check valve is below or equal to 10 kPa, such as between 10 Pa and 10 kPa, between 100 Pa and 10 kPa or between 1 kPa and 10 kPa. A too high opening pressure can give rise to pressure build-up and uncontrolled burst of fluid, while a too low opening pressure may cause the valve to open e.g. from pressure fluctuations induced by the agitation. The opening pressure is the minimum pressure difference between the two sides (inlet side and outlet side) of the check valve, which will cause the check valve to open. It can easily be determined with standard method, e.g. by gradually increasing the pressure on the inlet side and noting at which pressure the valve opens.
  • In some embodiments, the check valve comprises an elastomeric closing member 38;48;58;68. Elastomeric closing members facilitate the construction of check valves without stagnant zones and are well compatible with single use bioreactor vessels. It is also possible to have an addition tube with an integrally formed elastomeric check valve closing member, such that no separate assembly of valve parts is needed.
  • In certain embodiments, the elastomeric closing member is selected from the group consisting of tubes, lips, flaps and split disks. An example of a tubular closing member 58 is shown in FIG. 6 , an example of lips 48 in FIG. 5 , a flap 68 in FIG. 7 and a split disk 38 in FIG. 4 . All these constructions can be made with no or minimal outside stagnant zones and they are suitable for use in bioreactors.
  • In some embodiments, the vessel comprises a flexible plastic bag 2;22. This allows for single use bioreactors. The flexible plastic bag 2 can e.g. be supported by a rigid support structure 18 during use. The rigid support structure can be made from e.g. stainless steel.
  • In certain embodiments the agitation means comprises an impeller 4. The impeller is suitably located in the inner volume of the vessel and can be arranged to rotate or oscillate, e.g. by the action of an external magnetic drive.
  • In some embodiments the flexible plastic bag 22 is inflatable and the agitation means comprises a movable support platform 24 for the flexible plastic bag. As illustrated in FIG. 3 , the inflated bag can be self-supporting and can rest on the platform 24, which can be movable around an axis 28 to generate an oscillatory rocking agitation.
  • In certain embodiments the bioreactor or the vessel, including the addition tube and optionally the agitation means, is radiation sterilized. This is convenient for single-use bioreactors and can be achieved when all the components are made from radiation stable materials. Suitable materials for the vessel and the addition tube can be e.g. polyethylene and ethylene copolymers, while suitable elastomers for the closing member of the check valve can be e.g. radiation stable silicones.
  • In some embodiments the addition tube is fluidically connected to a supply vessel containing a liquid solution comprising a pH regulator, a nutrient and/or a growth factor. The liquid solution can be e.g. aqueous ammonia for pH control, but it can also be more complex media component solutions.
  • In one aspect the present invention discloses a method of cell cultivation, which comprises the steps of:
  • a) providing a bioreactor as described above;
  • b) adding cell cultivation medium and cells to the inner volume of the vessel;
  • c) providing agitation by the agitation means, and
  • d) adding a liquid solution and/or a gas to the inner volume via the addition tube.
  • The cells can be e.g. i) animal cells, such as mammalian or insect cells, ii) microorganisms such as bacteria or yeast cells or iii) plant cells.
  • In certain embodiments the amount of cell cultivation medium in step b) is sufficient to immerse the delivery orifice of the addition tube.
  • In some embodiments the liquid solution comprises a pH regulator, a nutrient and/or a growth factor.
  • This written description uses examples to disclose the invention, including the best mode, and also to enable any person skilled in the art to practice the invention, including making and using any devices or systems and performing any incorporated methods. The patentable scope of the invention is defined by the claims, and may include other examples that occur to those skilled in the art. Such other examples are intended to be within the scope of the claims if they have structural elements that do not differ from the literal language of the claims, or if they include equivalent structural elements with insubstantial differences from the literal languages of the claims. Features from different embodiments may be combined to form new embodiments.

Claims (20)

1. A bioreactor comprising:
a vessel defining an inner volume configured to contain liquid contents;
an agitation means;
at least one addition tube configured to introduce reagents from outside the bioreactor, the at least one addition tube having a first end protruding into the inner volume of the vessel to be in direct contact with the liquid contents of the vessel wherein cultivation takes place and a second end residing outside of the bioreactor; and
a check valve having a delivery orifice adjacent the first end of the at least one addition tube, with the delivery orifice configured to be immersed in direct contact with the liquid contents of the vessel wherein cultivation takes place, the check valve comprising a closing member covering the delivery orifice allowing flow of a fluid in a downward direction along gravity from the second end, through the addition tube and through the delivery orifice into the inner volume of the vessel and blocking flow in the reverse direction, wherein there is no or minimal stagnant zones outside the check valve.
2. The bioreactor of claim 1, wherein the check valve has an opening pressure of between 10 Pa and 10 kPa.
3. The bioreactor of claim 1, wherein the closing member is elastomeric.
4. The bioreactor of claim 3, wherein the elastomeric closing member is selected from the group consisting of tubes, lips, flaps and split disks.
5. The bioreactor of claim 1, wherein the vessel comprises a flexible plastic bag.
6. The bioreactor of claim 5, wherein the flexible plastic bag is arranged to be supported by a rigid support structure during use.
7. The bioreactor of claim 1, wherein the agitation means comprises an impeller.
8. The bioreactor of claim 5, wherein the flexible plastic bag is inflatable and the agitation means comprises a movable support platform for the flexible plastic bag.
9. The bioreactor of claim 1, wherein the addition tube is fluidically connected to a supply vessel containing a liquid solution comprising a pH regulator, a nutrient and/or a growth factor.
10. The bioreactor of claim 1, wherein the check valve has an opening pressure of between 100 Pa and 10 kPa.
11. A bioreactor comprising,
a vessel defining an inner volume configured to contain liquid contents;
an agitation means;
at least one addition tube configured to introduce reagents from outside the bioreactor, the at least one addition tube having a first end protruding into the inner volume of the vessel to be in direct contact with the liquid contents of the vessel wherein cultivation takes place; and
a check valve having a delivery orifice adjacent the first end of the at least one addition tube, with the delivery orifice configured to be immersed in direct contact with the liquid contents of the vessel wherein cultivation takes place, for allowing flow of a fluid in a downward direction along gravity from the addition tube into the inner volume through the delivery orifice and blocking flow in the reverse direction, such that there is no or minimal stagnant zones outside the check valve.
12. The bioreactor of claim 11, wherein the at least one addition tube is further configured such that the first end protruding into the inner volume of the vessel is located near a bottom of the vessel.
13. The bioreactor of claim 11, wherein the check valve has an opening pressure of between 10 Pa and 10 kPa.
14. The bioreactor of claim 11, wherein the check valve comprises an elastomeric closing member selected from the group consisting of tubes, lips, flaps and split disks.
15. The bioreactor of claim 11, wherein the vessel comprises a flexible plastic bag.
16. The bioreactor of claim 15, wherein the flexible plastic bag is arranged to be supported by a rigid support structure during use.
17. The bioreactor of claim 11, wherein the agitation means comprises an impeller.
18. The bioreactor of claim 15, wherein the flexible plastic bag is inflatable and the agitation means comprises a movable support platform for the flexible plastic bag.
19. The bioreactor of claim 11, wherein the addition tube is fluidically connected to a supply vessel containing a liquid solution comprising a pH regulator, a nutrient and/or a growth factor.
20. The bioreactor of claim 11, wherein the check valve has an opening pressure of between 100 Pa and 10 kPa.
US18/062,481 2013-08-27 2022-12-06 Bioreactor with addition tube Pending US20230093940A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US18/062,481 US20230093940A1 (en) 2013-08-27 2022-12-06 Bioreactor with addition tube

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/SE2013/051001 WO2015030639A1 (en) 2013-08-27 2013-08-27 Bioreactor with addition tube
US201614910824A 2016-02-08 2016-02-08
US18/062,481 US20230093940A1 (en) 2013-08-27 2022-12-06 Bioreactor with addition tube

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
PCT/SE2013/051001 Continuation WO2015030639A1 (en) 2013-08-27 2013-08-27 Bioreactor with addition tube
US14/910,824 Continuation US11549091B2 (en) 2013-08-27 2013-08-27 Bioreactor with addition tube

Publications (1)

Publication Number Publication Date
US20230093940A1 true US20230093940A1 (en) 2023-03-30

Family

ID=52587036

Family Applications (2)

Application Number Title Priority Date Filing Date
US14/910,824 Active 2036-03-11 US11549091B2 (en) 2013-08-27 2013-08-27 Bioreactor with addition tube
US18/062,481 Pending US20230093940A1 (en) 2013-08-27 2022-12-06 Bioreactor with addition tube

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US14/910,824 Active 2036-03-11 US11549091B2 (en) 2013-08-27 2013-08-27 Bioreactor with addition tube

Country Status (5)

Country Link
US (2) US11549091B2 (en)
EP (1) EP3039115B2 (en)
JP (1) JP2016531578A (en)
CN (1) CN105473701A (en)
WO (1) WO2015030639A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3039115B2 (en) 2013-08-27 2022-04-06 Cytiva Sweden AB Bioreactor with addition tube
DE102013109819A1 (en) * 2013-09-09 2015-03-12 Sartorius Stedim Biotech Gmbh Container with flexible wall
US20190127677A1 (en) * 2016-04-18 2019-05-02 Toyo Seikan Group Holdings, Ltd. Container for cell culture and use method therefor
JP7104634B2 (en) * 2016-05-11 2022-07-21 コーニング インコーポレイテッド Structured bag for cell culture
CA3026170A1 (en) * 2016-06-03 2017-12-07 Lonza Limited Single use bioreactor
CN109689853B (en) 2016-08-27 2022-08-23 三维生物科技有限公司 Bioreactor
EP3559200A2 (en) * 2016-12-23 2019-10-30 Brewjacket, Inc. Flexible fermentation vessel and uses thereof
KR102041088B1 (en) * 2018-02-19 2019-11-06 (주)마이크로디지탈 Disposable cell culture bag
US20200148987A1 (en) * 2018-11-13 2020-05-14 Ge Healthcare Bio-Sciences Corp. Apparatus, system and method for bioprocessing

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS465321Y1 (en) * 1967-03-22 1971-02-24
US3634750A (en) 1970-04-23 1972-01-11 Westinghouse Electric Corp Regulator apparatus responsive to generator output power factor and voltage
US4713345A (en) * 1985-07-29 1987-12-15 Grain Processing Corporation Fermentation methods and apparatus
JPH0622459B2 (en) * 1988-10-27 1994-03-30 ヤマエ食品工業株式会社 Low salt soy sauce manufacturing method
JP3009386U (en) 1994-08-24 1995-04-04 永田醸造機械株式会社 Stirrer for fermentation tanks
JPH0884980A (en) * 1994-09-16 1996-04-02 Nemoto Kikaku Kogyo Kk Agitation device for garbage disposal machine
US5832973A (en) * 1997-10-14 1998-11-10 Bristol-Myers Squibb Company Sanitary carbon charging system
JP3432459B2 (en) * 1999-08-02 2003-08-04 山▲ざき▼醸造 株式会社 Moromi pressed solid-liquid separation method
US6402941B1 (en) 2000-02-07 2002-06-11 Wastewater Biological Solutions, Corp Apparatus for biological treatment of environmental contaminants and waste
KR100698549B1 (en) * 2001-06-04 2007-03-21 에스케이케미칼주식회사 Culture medium of microorganism for treatmenting waste water
US7875448B2 (en) 2004-01-12 2011-01-25 Single Use Brx, Llc Bioreactor systems and disposable bioreactor
CN2708994Y (en) * 2004-06-25 2005-07-13 新疆新峰股份有限公司 Continuous production agitated reactor
DE202005014713U1 (en) 2004-09-22 2005-12-22 Sartorius Ag Laboratory fermentation vessel has twist-fit detachable valve assembly with parallel passage and duct
US8603805B2 (en) 2005-04-22 2013-12-10 Hyclone Laboratories, Inc. Gas spargers and related container systems
WO2009067518A1 (en) * 2007-11-20 2009-05-28 3M Innovative Properties Company Sample preparation container and method
WO2009116002A1 (en) 2008-03-19 2009-09-24 Sartorius Stedim Biotech Gmbh Mixing vessel
US8999702B2 (en) 2008-06-11 2015-04-07 Emd Millipore Corporation Stirred tank bioreactor
WO2010008578A2 (en) 2008-07-18 2010-01-21 Mascoma Corporation Flow-through biological conversion of lignocellulosic biomass
US20110236932A1 (en) * 2008-12-19 2011-09-29 Stobbe Tech A/S Biopharmaceutical plant in a column
US9550971B2 (en) * 2009-04-14 2017-01-24 Therapeutic Proteins International, LLC Universal bioreactors and methods of use
WO2011006019A2 (en) * 2009-07-08 2011-01-13 Moustafa Ahmed El-Shafie Method and system for processing a biomass for producing biofuels and other products
US9060538B2 (en) 2009-12-25 2015-06-23 Kikkoman Corporation Soy sauce having hypotensive effects and method for producing the same
KR101342154B1 (en) * 2010-03-09 2013-12-13 이엠디 밀리포어 코포레이션 Process bag container with sensors
US9969965B2 (en) * 2011-01-11 2018-05-15 Ge Healthcare Bio-Sciences Corp. Linearly scalable single use bioreactor system
JP5923529B2 (en) 2011-03-18 2016-05-24 ジーイー・ヘルスケア・バイオサイエンス・アクチボラグ Flexible bag for cell culture
DE102011050623B4 (en) 2011-05-24 2013-01-31 2Mag Ag stirrer
WO2012167179A1 (en) * 2011-06-03 2012-12-06 Proterro, Inc. Self contained solid phase photobioreactor
US20130005010A1 (en) * 2011-06-30 2013-01-03 Peter Simpson Bell Bioreactor for syngas fermentation
GB2495934A (en) 2011-10-25 2013-05-01 Tap Biosystems Phc Ltd Bioreactor outlet air conditioning systems and associated methods
CN202638388U (en) * 2012-06-04 2013-01-02 潍坊泉鑫化工有限公司 Mild reaction liquid dropping device of reaction kettle
CN103043876B (en) * 2012-12-25 2013-11-06 北京工业大学 Method for reinforcing sludge digestion and synchronizing nitrogen and phosphorus removal
EP3039115B2 (en) 2013-08-27 2022-04-06 Cytiva Sweden AB Bioreactor with addition tube

Also Published As

Publication number Publication date
CN105473701A (en) 2016-04-06
WO2015030639A1 (en) 2015-03-05
EP3039115B1 (en) 2019-06-12
JP2016531578A (en) 2016-10-13
EP3039115A4 (en) 2017-04-26
US20160194591A1 (en) 2016-07-07
US11549091B2 (en) 2023-01-10
EP3039115B2 (en) 2022-04-06
EP3039115A1 (en) 2016-07-06

Similar Documents

Publication Publication Date Title
US20230093940A1 (en) Bioreactor with addition tube
US11162062B2 (en) Methods and apparatus for gas stream mass transfer with a liquid
US10760041B2 (en) Cell culture bag with internal dialysis membrane
KR101386026B1 (en) Stirred Tank Bioreactor
US20090199904A1 (en) Low shear pumps for use with bioreactors
WO2015180908A1 (en) Bag assembly for cultivation of cells
CN108138103A (en) Bioreactor with the supply of interruptable gas
US20230313110A1 (en) System and method for draining a flexible bioprocessing bag
US10934515B2 (en) Passive automatic antifoam delivery system for use with single-use bioreactors
US9683207B2 (en) Method for growing cells in hollow fibers
JP2022553897A (en) Sparger Apparatus for Bioprocess Systems and Method of Making Sparger Apparatus
AU2010316952B2 (en) Method for expanding and/or preserving cells by means of gas enrichment of the culture medium
US11447730B2 (en) Bioreactor system and method of bioprocessing
EP4141100A1 (en) Gas introducing device for bioreactor
CN101787348A (en) Biomimetic bioreactor for enhancing mass and heat transfer
CN102258817A (en) Helical hollow fiber tube artificial liver bioreactor
US20210016287A1 (en) Reinforced bioreactor component structure system for cell cultivation
US20240018453A1 (en) Bioprocessing vessel having integral fluid conduit
EP3831922A1 (en) Roller tube culture system
CN208517382U (en) A kind of multi-functional culture solution packing pipe and sub-packaging system
US20230092138A1 (en) External circulation renewal device of culture media and ventilation device for bioreactor
CN105254114B (en) A kind of simple membrane bioreactor and application method
JP2021191234A (en) Cell culture tank
WO2017013974A1 (en) Stirring device
PH12017000313A1 (en) System for bubble-forming and harvesting in a liquid culturing apparatus

Legal Events

Date Code Title Description
AS Assignment

Owner name: CYTIVA SWEDEN AB, SWEDEN

Free format text: CHANGE OF NAME;ASSIGNOR:GE HEALTHCARE BIO-SCIENCES AB;REEL/FRAME:062078/0480

Effective date: 20200612

Owner name: GE HEALTHCARE BIO-SCIENCES AB, SWEDEN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:CASTAN, ANDREAS;GEBAUER, KLAUS;SIGNING DATES FROM 20140317 TO 20140414;REEL/FRAME:062001/0165

STPP Information on status: patent application and granting procedure in general

Free format text: SENT TO CLASSIFICATION CONTRACTOR

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED